NEURONES (NRO.PA)

Every figure this model derived for NRO.PA, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 340,781,000 CashAndCashEquivalents 2026-01-01
current assets 608,529,000 CurrentAssets 2026-01-01
current liabilities 250,055,000 CurrentLiabilities 2026-01-01
equity 399,980,000 EquityAttributableToOwnersOfParent 2026-01-01
ocf 71,282,000 CashFlowsFromUsedInOperatingActivities 2025-12-31
revenue 857,175,000 RevenueFromContractsWithCustomers 2025-12-31
sbc 4,212,000 AdjustmentsForSharebasedPayments 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up NRO.PA on one particular measure came for.

RatioValue
cash operating margin9.31
current ratio2.43
current ratio reported2.43
fcf margin8.32
operating margin8.82
owner earnings margin7.82
revenue growth5.78
revenue growth per share5.78
roic99.59
rule of 4014.6
sbc pct revenue0.49

What to be careful about

What this model itself distrusts about NRO.PA's figures. Written by the derivation as it ran, not added afterwards.